Advanced in MYH9 Related Thrombocytopenia

Jian P. Li

Holistic Medicine
2401 Research Blvd, 
Rockville, MD 
Advanced in MYH9 Related Thrombocytopenia
2401 Research Blvd, 
Rockville, MD 
OverviewInsuranceLocationsClinical Research

Overview

Jian Li is a Holistic Medicine provider in Rockville, Maryland. Ms. Li is rated as an Advanced provider by MediFind in the treatment of MYH9 Related Thrombocytopenia. Her top areas of expertise are Gallbladder Disease, Trichinosis, Atrial Tachycardia, Endoscopy, and Bone Graft.

Her clinical research consists of co-authoring 5609 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of MYH9 Related Thrombocytopenia.

Specialties
Holistic Medicine
Licenses
Acupuncturist in MA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

2401 Research Blvd, Rockville, MD 20850

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled Trial
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled Trial
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Drugs: Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin
Study Phase: Phase 4
A Multicenter Study of Prognosis and the Efficacy Comparison of Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Patients(Clinical Risk Score≥3) of Resectable Colorectal Liver Metastasis
A Multicenter Study of Prognosis and the Efficacy Comparison of Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Patients(Clinical Risk Score≥3) of Resectable Colorectal Liver Metastasis
Enrollment Status: Completed
Publish Date: February 01, 2021
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer
Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer
Enrollment Status: Terminated
Publish Date: April 07, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

5604 Total Publications

Two strains of Bacillus velezensis: potent probiotics against Escherichia coli K99-induced diarrhea with high safety in mice.
Two strains of Bacillus velezensis: potent probiotics against Escherichia coli K99-induced diarrhea with high safety in mice.
Journal: Microbiology spectrum
Published: October 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Li's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 46 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile